Pacira BioSciences Inc header image

Pacira BioSciences Inc

PCRX

Equity

ISIN null / Valor 12338490

NASDAQ (2026-10-30)
USD 36.39%

Pacira BioSciences Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a specialty pharmaceutical company that develops and commercializes non‑opioid, postsurgical pain management therapies built around its proprietary DepoFoam drug‑delivery technology; its flagship product, EXPAREL (bupivacaine liposome injectable suspension), is used by hospitals, ambulatory surgery centers and surgical specialists to provide prolonged local analgesia and reduce perioperative opioid use. The company markets its products through a targeted sales force to anesthesiologists, surgeons and perioperative teams, pursues regulatory approvals and label expansions to broaden clinical use, and maintains a research and development pipeline to extend its delivery platform to additional formulations and indications, while operating both in the United States and select international markets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

71.1%1Y
31.0%3Y
-30.4%5Y

Performance

52.5%1Y
60.8%3Y
52.2%5Y

Volatility

Market cap

1451 M

Market cap (USD)

Daily traded volume (Shares)

737,238

Daily traded volume (Shares)

1 day high/low

19.4 / 18.895

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.97%USD 18.94
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 37.41
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%USD 412.62
Zydus Lifesciences Limited
Zydus Lifesciences Limited Zydus Lifesciences Limited Valor: 29835501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.89%INR 1,244.00
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%INR 1,719.70
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.93%USD 204.78
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%EUR 40.40
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%INR 1,906.30
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%USD 82.22
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.57%USD 92.01